Rockwell Medical (RMTI) Accounts Payables (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Accounts Payables came in at $3.4 million in Q1 2026, up 79.01% YoY from $1.9 million in Q1 2025, and up 72.39% on a QoQ basis from $2.0 million in Q4 2025.
Rockwell Medical (RMTI) Accounts Payables (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Accounts Payables data on file, last reported at $3.4 million in Q1 2026.
- Quarterly Accounts Payables rose 79.01% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (up 79.01% YoY) and the FY2025 annual result came in at $2.0 million, down 30.32% from the prior year.
- Accounts Payables advanced to $3.4 million in Q1 2026, from $2.0 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $5.9 million in Q2 2023 to a low of $1.5 million in Q2 2025.
- A 5-year average of $3.4 million and a median of $3.3 million in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2023 — Accounts Payables jumped 101.46% — and 2025, when it slumped 60.87%.
- Tracing RMTI's Accounts Payables over 5 years: stood at $4.1 million in 2022, then advanced by 11.42% to $4.5 million in 2023, then sank by 36.47% to $2.9 million in 2024, then plunged by 30.32% to $2.0 million in 2025, then jumped by 72.39% to $3.4 million in 2026.
- The last three Accounts Payables figures came in at $3.4 million (Q1 2026), $2.0 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | Rockwell Medical | 31.73 Mn | 6.93 Mn | 3.24 Mn | 3.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.18 Mn |
| Mar 31, 2026 | 3.45 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 1.52 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 2.87 Mn |
| Sep 30, 2024 | 2.61 Mn |
| Jun 30, 2024 | 3.35 Mn |
| Mar 31, 2024 | 4.92 Mn |
| Dec 31, 2023 | 4.52 Mn |
| Sep 30, 2023 | 3.93 Mn |
| Jun 30, 2023 | 5.93 Mn |
| Mar 31, 2023 | 5.20 Mn |
| Dec 31, 2022 | 4.05 Mn |
| Sep 30, 2022 | 3.05 Mn |
| Jun 30, 2022 | 2.94 Mn |
| Mar 31, 2022 | 4.22 Mn |
| Dec 31, 2021 | 3.74 Mn |
| Sep 30, 2021 | 4.83 Mn |